Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Virpax Pharmaceuticals Inc
VRPXCurrent price
0.76 USD
+0.0075 USD (+1.00%)
Last closed
0.71 USD
Company
www.virpaxpharma.com
ISIN
US9282511073
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 552 781 USD
Yield for 12 month
-89.33 %
1Y
3Y
5Y
10Y
15Y
VRPX
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and NobrXiol, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania. Address: 1055 Westlakes Drive, Berwyn, PA, United States, 19312
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures VRPX
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-91.42 %
PEG Ratio
–
Return On Equity TTM
-362.29 %
Wall Street Target Price
3 USD
Revenue TTM
–
Book Value
-0.99 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-13.25 USD
Diluted Eps TTM
-13.25 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics VRPX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VRPX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
01.03.2024
Dividend Date
–
Stock Valuation VRPX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.0485
Price Book MRQ
0.4844
Financials VRPX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VRPX
For 52 weeks
0.36 USD
8 USD
50 Day MA
0.69 USD
Shares Short Prior Month
385 557
200 Day MA
1.9 USD
Short Ratio
2.92
Shares Short
565 470
Short Percent
12.33 %
BeatStart